Canada markets closed

Evome Medical Technologies Inc. (LNDZF)

OTC Markets OTCPK - OTC Markets OTCPK Delayed Price. Currency in USD
Add to watchlist
0.20000.0000 (0.00%)
At close: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close0.2000
Bid0.0111 x 0
Ask0.1500 x 0
Day's Range0.1000 - 0.1000
52 Week Range0.0400 - 0.3150
Avg. Volume814
Net AssetsN/A
PE Ratio (TTM)N/A
YTD Daily Total ReturnN/A
Beta (5Y Monthly)N/A
Expense Ratio (net)N/A
Inception DateN/A
  • GlobeNewswire

    Evome Medical Technologies Retains irlabs for Investor Relations Services

    NEW YORK, July 03, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company” or “Evome”) (TSXV: EVMT) is pleased to announce it has entered into an agreement ("Agreement") with IR Labs Inc. ("irlabs") to provide the Company with investor relations and communications services. “We look forward to this partnership with irlabs as we work to raise our profile in the investment community,” said Mike Seckler, CEO. “In tandem with their expert team, we’re confident we can amplify our stor

  • GlobeNewswire

    Evome Medical Technologies Announces Securities Issuances

    NEW YORK, June 14, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company” or “Evome”) (TSXV: EVMT) announces it has received conditional approval from the TSX Venture Exchange (the “TSXV”) to complete a shares for services transaction with Beacon Securities Limited (“Beacon”) pursuant to ‎which the Company will issue Beacon ‎504,286 ‎common ‎shares of the Company at a deemed price of ‎$0.1983 per share in satisfaction of $100,000 of advisory services. The shares issuable will be

  • GlobeNewswire

    Evome Medical Technologies Announces Update Call with CEO Mike Seckler for Tuesday, June 4, 2024; Provides Update on Strong Q2

    NEW YORK, June 03, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company” or “Evome”) (TSXV: EVMT) today provided details on preliminary estimated revenues and margins from April and May 2024, the first two months of the second quarter. Mike Seckler, Chief Executive Officer of the Company, will also hold a call to update shareholders on the first quarter financials, second quarter progress and future plans of the Company. Revenue Growth Update for Q2 2024 For April and May 2024,